/

Biotech and Pharmaceutical

Incannex Healthcare

Advising on acquisition of medicinal cannabis research and development company APIRx.

KEY PEOPLE:

Melbourne

David Schiavello

Melbourne

Lisa Marcus

Related Insights

What's new?

View All Insights

Intellectual Property

Practical strategies for obtaining expert evidence in intellectual property proceedings

As intellectual property law develops through changes to legislation and continued litigation through the courts, and changes to Court Rules and Practice Notes occur, the ways in which experts are instructed and evidence is obtained from them has also needed to change and evolve.

Intellectual Property

New standalone legislation for protection of Indigenous cultural and intellectual property

The Australian Government is currently undertaking a scoping study to determine how new stand-alone legislation could help Aboriginal and Torres Strait Islander people to protect and commercialise Indigenous Cultural and Intellectual Property.

Intellectual Property

Franchisors beware: Major Australian franchisor fined to the tune of $1.5 million

A record fine for contempt of court in a proceeding brought by the competition watchdog has been ordered against a franchisor by the Federal Court of Australia.

Intellectual Property

Call It What You Want: Branding lessons from Taylor Swift

Many people are becoming tired of hearing about Taylor Swift after the Australian leg of her Eras Tour swept the country recently.

Intellectual Property

Can 'indifference' excuse liability for copyright infringement?

A recent decision by the High Court of Australia has affirmed that companies that are 'indifferent' to copyright infringement can be held liable for authorising the infringement, but that specific evidence is needed to prove this.

Intellectual Property

Reversing the burden of proof in patent infringement proceedings

The recent case of Calix Limited v Grenof Pty Ltd & Aquadex Pty Ltd (Calix v Grenof) marks the first time the Federal Court of Australia has analysed section 121A of the Patents Act 1990 (Cth) (Act), a provision that reverses the burden of proof in patent infringement proceedings under specific circumstances.

Intellectual Property

Patent infringement defence reaches boiling point at trial

The importance of selecting appropriately skilled expert witnesses for patent infringement cases was highlighted in a recent Federal Court of Australia decision.

Intellectual Property

NZ honey producers withdraw from battle over “Manuka Honey” trade mark: lessons from the dispute

The recent end to the Manuka Honey trade mark dispute has demonstrated the importance of distinctiveness when seeking to register certification trade marks in Australia and overseas.

View All Insights

Follow us

Navigation

About us

Thomson Geer is one of Australia's largest independent corporate law firms. We are trusted by companies, governments and institutions to act for their commercial and legal interests.

Thomson Geer acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.